Price
CHART BY
Frequently asked questions
What is Strata Critical Medical, Inc. Class A's market capitalization?
What is the Earnings Per Share (EPS) for Strata Critical Medical, Inc. Class A?
What are the analyst ratings and target price for Strata Critical Medical, Inc. Class A's stock?
What is Strata Critical Medical, Inc. Class A's revenue over the trailing twelve months?
What is the EBITDA for Strata Critical Medical, Inc. Class A?
What is the free cash flow of Strata Critical Medical, Inc. Class A?
How many employees does Strata Critical Medical, Inc. Class A have, and what sector and industry does it belong to?
What is the free float of Strata Critical Medical, Inc. Class A's shares?
Financials
- Market Cap
- $384.79M
- EPS (TTM)
- -$0.238
- Free Float
- 56.87M
- Revenue (TTM)
- $254.34M
- EBITDA (TTM)
- -$18.16M
- Free Cashflow (TTM)
- -$23.98M
Pricing
- 52W span
- $2.355$6.00
Analyst Ratings
The price target is $7.833 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the U.S. healthcare industry. It operates one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated ‘one call’ solution for donor organ recovery. Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.
- Employees
- 322
- Industries
- Medical/ Nursing Services
- Sector
- Health Care
Identifier
- Primary Ticker
- BLDE